WebHikma Pharmaceuticals has signed an agreement to acquire for $17.0m pipeline epinephrine and naloxone nasal sprays and a complementary manufacturing platform from Insys Therapeutics, which recently filed for bankruptcy.Both the epinephrine and naloxone sprays are intended for approval through the US Food and Drug Administration’s hybrid …
Hikma Pharmaceuticals Acquires Arab Pharmaceutical …
WebApr 11, 2024 · Hikma Pharmaceuticals PLC is a pharmaceutical company. The Company’s principal activities are the development, manufacturing, marketing and selling of a range … WebAt Hikma, you can lean on us to deliver high quality medicines that put better health within reach every day. Right now, we develop, manufacture and distribute a broad range of … heng tai house
Hikma Pharmaceuticals Plc (HKMPF) 2024 Interim Results - SeekingAlpha
WebDec 26, 2024 · The company has established a diversified R&D pipeline comprising over 50 drug candidates, with five therapeutic focus areas covering cancer, autoimmune, metabolic, neurological, and infectious... Web2- Commercial Readiness (Sales & Marketing) 3- Pipeline & Portfolio management. 4- NPI (New Product Introduction) 5- S&OP (Sales & Operational Planning) * Master degree holder of Business Administration & marketing concentration from German Jordanian. University. * Certified Emotional Intelligence Practitioner from six seconds. www.6seconds.org. WebApr 12, 2024 · Key statistics As of last trade, Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,650.00, 40.49% above the 52 week low of 1,174.50 set on Oct 24, 2024. 52-week range Today 1,174.50 Oct 24 2024... la redoute converse blanche femme